Laminin-111-derived peptides and cancer

Cell Adhesion and Migration

Volumn 7, Issue 1, 2013, Pages 150-159

  Kikkawa, Yamato ^a   Hozumi, Kentaro ^a   Katagiri, Fumihiko ^a   Nomizu, Motoyoshi ^a   Kleinman, Hynda K ^b   Koblinski, Jennifer E ^c  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adhesion; Angiogenesis; Basement membrane; Laminin 111; Metastasis; Migration; Proteases; Synthetic peptide; Tumor growth

Indexed keywords

FLUOROURACIL; GELATINASE A; GELATINASE B; INTEGRIN RECEPTOR; LAMININ 111; LAMININ ALPHA1 CHAIN; LAMININ BETA1 CHAIN; LAMININ GAMMA1; MACROGOL; PROTEIN BCL 2; PROTEIN DERIVATIVE; SYNDECAN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 5; VERY LATE ACTIVATION ANTIGEN 6;

ALPHA CHAIN; AMINO ACID SEQUENCE; ANGIOGENESIS; BETA CHAIN; CELL ADHESION; CELL MIGRATION; COLONY FORMATION; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NEOPLASM; NONHUMAN; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 84872192988     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.22827     Document Type: Review

References (101)

1. Engbring JA, Kleinman HK. The basement membrane matrix in malignancy. J Pathol 2003; 200:465-70; PMID:12845613; http://dx.doi.org/10.1002/path.1396
2. Kleinman HK, Koblinski J, Lee S, Engbring J. Role of basement membrane in tumor growth and metastasis [ix.]. Surg Oncol Clin N Am 2001; 10:329-38, ix; PMID:11382590
3. Terranova VP, Williams JE, Liotta LA, Martin GR. Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. Science 1984; 226: 982-5; PMID:6505678; http://dx.doi.org/10.1126/science.6505678
4. Terranova VP, Liotta LA, Russo RG, Martin GR. Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res 1982; 42:2265-9; PMID: 7074609
5. Khan KM, Falcone DJ. Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. J Biol Chem 1997; 272:8270-5; PMID:9079647; http://dx.doi.org/10.1074/jbc.272.13. 8270
6. Turpeenniemi-Hujanen T, Thorgeirsson UP, Rao CN, Liotta LA. Laminin increases the release of type IV collagenase from malignant cells. J Biol Chem 1986; 261:1883-9; PMID:3003087
7. Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983; 49:636-49; PMID:6317982
8. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 1992; 282:273-8; PMID:1540143
9. Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer. Clin Chim Acta 2000; 291: 113-35; PMID:10675719; http://dx.doi.org/10. 1016/S0009-8981(99)00224-7
10. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000; 148:615-24; PMID:10662785; http://dx.doi.org/10.1083/jcb.148.3. 615
11. Visscher DW, Sloane BF, Sameni M, Babiarz JW, Jacobson J, Crissman JD. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia. Mod Pathol 1994; 7:76-81; PMID: 8159656
12. Zheng WQ, Looi LM, Cheah PL. Correlation between laminin and cathepsin D expressions in breast carcinoma. Tumori 2002; 88:296-9; PMID:12400981
13. Ioachim E, Kamina S, Kontostolis M, Agnantis NJ. Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and proliferative indices in breast cancer. Virchows Arch 1997; 431:311-6; PMID:9463571; http://dx.doi.org/10.1007/s004280050104
14. Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL, et al. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 2002; 38: 2362-70; PMID:12460779; http://dx.doi.org/10.1016/S0959-8049(02)00210-1
15. Albrechtsen R, Nielsen M, Wewer U, Engvall E, Ruoslahti E. Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin. Cancer Res 1981; 41:5076-81; PMID: 7030483
16. Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003; 15:753-62; PMID:14644202; http://dx.doi.org/10.1016/j.ceb.2003.10.016
17. Gudjonsson T, Rønnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 2002; 115:39-50; PMID:11801722
18. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997; 277:225-8; PMID:9211848; http://dx.doi.org/10.1126/ science.277.5323.225
19. Nakai M, Mundy GR, Williams PJ, Boyce B, Yoneda T. A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice. Cancer Res 1992; 52:5395-9; PMID:1394144
20. Yamada Y, Kleinman HK. Functional domains of cell adhesion molecules. Curr Opin Cell Biol 1992; 4:819-23; PMID:1419059; http://dx.doi.org/10.1016/ 0955-0674(92)90105-L
21. Yamada KM. Adhesive recognition sequences. J Biol Chem 1991; 266:12809-12; PMID:2071570
22. Hozumi K, Akizuki T, Yamada Y, Hara T, Urushibata S, Katagiri F, et al. Cell adhesive peptide screening of the mouse laminin a1 chain G domain. Arch Biochem Biophys 2010; 503:213-22; PMID:20727343; http://dx.doi.org/10.1016/j. abb.2010.08.012
23. Nomizu M, Kuratomi Y, Ponce ML, Song SY, Miyoshi K, Otaka A, et al. Cell adhesive sequences in mouse laminin beta1 chain. Arch Biochem Biophys 2000; 378:311-20; PMID:10860548; http://dx.doi.org/10.1006/abbi.2000.1828
24. Nomizu M, Kim WH, Yamamura K, Utani A, Song SY, Otaka A, et al. Identification of cell binding sites in the laminin alpha 1 chain carboxyl-terminal globular domain by systematic screening of synthetic peptides. J Biol Chem 1995; 270:20583-90; PMID:7657636; http://dx.doi.org/10.1074/jbc. 270.35.20583
25. Nomizu M, Kuratomi Y, Malinda KM, Song SY, Miyoshi K, Otaka A, et al. Cell binding sequences in mouse laminin alpha1 chain. J Biol Chem 1998; 273: 32491-9; PMID:9829982; http://dx.doi.org/10.1074/jbc.273.49.32491
26. Nomizu M, Kuratomi Y, Song SY, Ponce ML, Hoffman MP, Powell SK, et al. Identification of cell binding sequences in mouse laminin gamma1 chain by systematic peptide screening. J Biol Chem 1997; 272: 32198-205; PMID:9405421; http://dx.doi.org/10.1074/jbc.272.51.32198
27. Graf J, Ogle RC, Robey FA, Sasaki M, Martin GR, Yamada Y, et al. A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67,000 laminin receptor. Biochemistry 1987; 26:6896-900; PMID:2962631; http://dx.doi.org/10.1021/bi00396a004
28. Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y, et al. YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987; 238:1132-4; PMID:2961059; http://dx.doi.org/10.1126/ science.2961059
29. Yamamura K, Kibbey MC, Jun SH, Kleinman HK. Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis. Semin Cancer Biol 1993; 4:259-65; PMID:8400148
30. Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci U S A 1990; 87:6698-702; PMID:2168554; http://dx.doi.org/10. 1073/pnas.87.17.6698
31. Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989; 58:933-43; PMID:2528412; http://dx.doi.org/10.1016/0092-8674(89)90945-8
32. Yamamura K, Kibbey MC, Kleinman HK. Melanoma cells selected for adhesion to laminin peptides have different malignant properties. Cancer Res 1993; 53:423-8; PMID:8417834
33. Kaneda Y, Yamamoto S, Kihira T, Tsutsumi Y, Nakagawa S, Miyake M, et al. Synthetic cell-adhesive laminin peptide YIGSR conjugated with polyethylene glycol has improved antimetastatic activity due to a longer half-life in blood. Invasion Metastasis 1995; 15:156-62; PMID:8621271
34. Kawasaki K, Namikawa M, Murakami T, Mizuta T, Iwai Y, Hama T, et al. Amino acids and peptides. XIV. Laminin related peptides and their inhibitory effect on experimental metastasis formation. Biochem Biophys Res Commun 1991; 174:1159-62; PMID:1996983; http://dx.doi.org/10.1016/0006-291X(91)91542-K
35. Murata J, Saiki I, Azuma I, Nishi N. Inhibitory effect of a synthetic polypeptide, poly(Tyr-Ile-Gly-Ser-Arg), on the metastatic formation of malignant tumour cells. Int J Biol Macromol 1989; 11:97-9; PMID:2489072; http://dx.doi.org/10.1016/0141-8130(89)90049-4
36. Nomizu M, Yamamura K, Kleinman HK, Yamada Y. Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumor growth and metastasis. Cancer Res 1993; 53:3459-61; PMID: 8339246
37. Hojo K, Maeda M, Mu Y, Kamada H, Tsutsumi Y, Nishiyama Y, et al. Facile synthesis of a chitosan hybrid of a laminin-related peptide and its antimetastatic effect in mice. J Pharm Pharmacol 2000; 52:67-73; PMID:10716605; http://dx.doi.org/10.1211/0022357001773526
38. Mu Y, Kamada H, Kodaira H, Sato K, Tsutsumi Y, Maeda M, et al. Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life. Biochem Biophys Res Commun 1999; 264:763-7; PMID:10544005; http://dx.doi.org/10.1006/ bbrc.1999.1567
39. Liotta LA, Stracke ML. Tumor invasion and metastases: biochemical mechanisms. Cancer Treat Res 1988; 40:223-38; PMID:2908652; http://dx.doi.org/ 10.1007/978-1-4613-1733-3-10
40. Stallmach A, Orzechowski HD, Feldmann P, Riecken EO, Zeitz M, Herbst H. 32/67-kD laminin receptor expression in human colonic neoplasia: elevated transcript levels correlate with the degree of epithelial dysplasia. Am J Gastroenterol 1999; 94:3341-7; PMID:10566741; http://dx.doi.org/10.1111/j.1572- 0241.1999.01550.x
41. Dubey PK, Singodia D, Vyas SP. Polymeric nanospheres modified with YIGSR peptide for tumor targeting. Drug Deliv 2010; 17:541-51; PMID: 20560774; http://dx.doi.org/10.3109/10717544.2010.490249
42. Dubey PK, Singodia D, Vyas SP. Liposomes modified with YIGSR peptide for tumor targeting. J Drug Target 2010; 18:373-80; PMID:20020817; http://dx.doi.org/10.3109/10611860903483388
43. Kouzi-Koliakos K, Koliakos G, Trontzos C, Papageorgiou A, Iliadis S, Triantos A, et al. In vivo binding of the radioiodinated peptide YIGSR on B16 melanoma cells. Invasion Metastasis 1996; 16:322-9; PMID:9371232
44. Lopez-Barcons LA, Polo D, Reig F, Fabra A. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes. J Biomed Mater Res A 2004; 69: 155-63; PMID:14999763; http://dx.doi.org/10.1002/jbm.a.20235
45. Sarfati G, Dvir T, Elkabets M, Apte RN, Cohen S. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin. Biomaterials 2011; 32:152-61; PMID: 20889205; http://dx.doi.org/10. 1016/j.biomaterials.2010.09.014
46. Ukawala M, Chaudhari K, Rajyaguru T, Manjappa AS, Murthy RS, Gude R. Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis. J Drug Target 2012; 20:55-66; PMID:21967151; http://dx.doi.org/10.3109/1061186X.2011.610799
47. Hu J, Zhang YX, Lan XL, Qin GM, Zhang J, Hu ZH. An imaging study using laminin peptide 99mTc-YIGSR in mice bearing Ehrlich ascites tumour. Chin Med J (Engl) 2005; 118:753-8; PMID:15899138
48. Koliakos KK, Sapountzi Z, Papageorgiou A, Trachana V, Kotsinou S, Koliakos G. Antiidiotypic antibodies carrying the "internal image" of peptide YIGSR inhibit spontaneous metastasis of Lewis lung carcinoma in mice. In Vivo 2002; 16:511-8; PMID:12494895
49. Bushkin-Harav I, Littauer UZ. Involvement of the YIGSR sequence of laminin in protein tyrosine phosphorylation. FEBS Lett 1998; 424:243-7; PMID:9539159; http://dx.doi.org/10.1016/S0014-5793(98)00180-X
50. Kim WH, Schnaper HW, Nomizu M, Yamada Y, Kleinman HK. Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin. Cancer Res 1994; 54:5005-10; PMID:8069868
51. Morais Freitas V, Nogueira da Gama de Souza L, Cyreno Oliveira E, Furuse C, Cavalcanti de Araújo V, Gastaldoni Jaeger R. Malignancy-related 67kDa laminin receptor in adenoid cystic carcinoma. Effect on migration and beta-catenin expression. Oral Oncol 2007; 43:987-98; PMID:17257887; http://dx.doi.org/10.1016/j.oraloncology.2006.11.005
52. Yu HN, Zhang LC, Yang JG, Das UN, Shen SR. Effect of laminin tyrosine-isoleucine-glycine-serine-arginine peptide on the growth of human prostate cancer (PC-3) cells in vitro. Eur J Pharmacol 2009; 616:251-5; PMID:19577562; http://dx.doi.org/10.1016/j.ejphar.2009.06.050
53. Sweeney TM, Kibbey MC, Zain M, Fridman R, Kleinman HK. Basement membrane and the SIKVAV laminin-derived peptide promote tumor growth and metastases. Cancer Metastasis Rev 1991; 10:245-54; PMID:1764767; http://dx.doi.org/10.1007/ BF00050795
54. Tashiro K, Sephel GC, Weeks B, Sasaki M, Martin GR, Kleinman HK, et al. A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J Biol Chem 1989; 264:16174-82; PMID:2777785
55. Bresalier RS, Schwartz B, Kim YS, Duh QY, Kleinman HK, Sullam PM. The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells. Cancer Res 1995; 55:2476-80; PMID:7758002
56. Kibbey MC, Grant DS, Kleinman HK. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J Natl Cancer Inst 1992; 84:1633-8; PMID:1279183; http://dx.doi.org/10.1093/jnci/84.21. 1633
57. Grant DS, Kinsella JL, Fridman R, Auerbach R, Piasecki BA, Yamada Y, et al. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol 1992; 153:614-25; PMID:1280280; http://dx.doi.org/10.1002/jcp.1041530324
58. Royce LS, Martin GR, Kleinman HK. Induction of an invasive phenotype in benign tumor cells with a laminin A-chain synthetic peptide. Invasion Metastasis 1992; 12:149-55; PMID:1294529
59. Freitas VM, Scheremeta B, Hoffman MP, Jaeger RG. Laminin-1 and SIKVAV a laminin-1-derived peptide, regulate the morphology and protease activity of a human salivary gland adenoid cystic carcinoma cell line. Oral Oncol 2004; 40:483-9; PMID:15006619; http://dx.doi.org/10.1016/j.oraloncology.2003.10.002
60. Mackay AR, Gomez DE, Nason AM, Thorgeirsson UP. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression. Lab Invest 1994; 70:800-6; PMID:8015284
61. Stack MS, Gray RD, Pizzo SV. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain. Cancer Res 1993; 53:1998-2004; PMID: 8481902
62. Freitas VM, Vilas-Boas VF, Pimenta DC, Loureiro V, Juliano MA, Carvalho MR, et al. SIKVAV, a laminin α1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway. Am J Pathol 2007; 171:124-38; PMID:17591960; http://dx.doi.org/10.2353/ajpath.2007.051264
63. Zamora PO, Eshima D, Graham D, Shattuck L, Rhodes BA. Biological distribution of 99mTc-labeled YIGSR and IKVAV laminin peptides in rodents: 99mTc-IKVAV peptide localizes to the lung. Biochim Biophys Acta 1993; 1182:197-204; PMID:8357851; http://dx.doi.org/10.1016/0925-4439(93)90141-M
64. Stevenson M, Hale AB, Hale SJ, Green NK, Black G, Fisher KD, et al. Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via alpha6-integrins. Cancer Gene Ther 2007; 14:335-45; PMID: 17235355; http://dx.doi.org/10.1038/sj.cgt.7701022
65. Nomizu M, Utani A, Shiraishi N, Kibbey MC, Yamada Y, Roller PP. The all-D-configuration segment containing the IKVAV sequence of laminin A chain has similar activities to the all-L-peptide in vitro and in vivo. J Biol Chem 1992; 267:14118-21; PMID: 1629212
66. Nascimento CF, de Siqueira AS, Pinheiro JJ, Freitas VM, Jaeger RG. Laminin-111 derived peptides AG73 and C16 regulate invadopodia activity of a human adenoid cystic carcinoma cell line. Exp Cell Res 2011; 317:2562-72; PMID:21924264; http://dx.doi.org/10.1016/j.yexcr.2011.08.022
67. Kim WH, Nomizu M, Song SY, Tanaka K, Kuratomi Y, KleinmanHK, et al. Laminin-alpha1-chain sequence Leu-Gln-Val-Gln-Leu-Ser-Ile-Arg (LQVQLSIR) enhances murine melanoma cell metastases. Int J Cancer 1998; 77:632-9; PMID:9679769; http://dx.doi.org/10.1002/(SICI)1097-0215(19980812)77:4〈632:: AID-IJC25〉3.0.CO;2-6
68. Song SY, Nomizu M, Yamada Y, Kleinman HK. Liver metastasis formation by laminin-1 peptide (LQVQLSIR)-adhesion selected B16-F10 melanoma cells. Int J Cancer 1997; 71:436-41; PMID:9139881; http://dx.doi.org/10.1002/(SICI)1097- 0215(19970502)71:3〈436::AID-IJC22〉3.0.CO;2-C
69. Yoshida Y, Hosokawa K, Dantes A, Kotsuji F, Kleinman HK, Amsterdam A. Role of laminin in ovarian cancer tumor growth and metastasis via regulation of Mdm2 and Bcl-2 expression. Int J Oncol 2001; 18:913-21; PMID:11295035
70. Suzuki N, Ichikawa N, Kasai S, Yamada M, Nishi N, Morioka H, et al. Syndecan binding sites in the laminin alpha1 chain G domain. Biochemistry 2003; 42:12625-33; PMID:14580209; http://dx.doi.org/10.1021/bi030014s
71. Siqueira AS, Gama-de-Souza LN, Arnaud MV, Pinheiro JJ, Jaeger RG. Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin. Tumour Biol 2010; 31:46-58; PMID:20237901; http://dx.doi.org/10. 1007/s13277-009-0008-x
72. Engbring JA, Hossain R, VanOsdol SJ, Kaplan-Singer B, Wu M, Hibino S, et al. The laminin alpha-1 chain derived peptide, AG73, increases fibronectin levels in breast and melanoma cancer cells. Clin Exp Metastasis 2008; 25:241-52; PMID:18185912; http://dx.doi.org/10.1007/s10585-007-9138-y
73. Suzuki N, Nakatsuka H, Mochizuki M, Nishi N, Kadoya Y, Utani A, et al. Biological activities of homologous loop regions in the laminin alpha chain G domains. J Biol Chem 2003; 278:45697-705; PMID: 12933811; http://dx.doi.org/10. 1074/jbc.M304667200
74. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003; 112:453-65; PMID:12600310; http://dx.doi.org/10.1016/S0092-8674(03)00120-X
75. Mochizuki M, Philp D, Hozumi K, Suzuki N, Yamada Y, Kleinman HK, et al. Angiogenic activity of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT). Arch Biochem Biophys 2007; 459:249-55; PMID:17286955; http://dx.doi.org/10.1016/ j.abb.2006.12.026
76. Hozumi K, Suzuki N, Nielsen PK, Nomizu M, Yamada Y. Laminin alpha1 chain LG4 module promotes cell attachment through syndecans and cell spreading through integrin alpha2beta1. J Biol Chem 2006; 281:32929-40; PMID:16945929; http://dx.doi.org/10.1074/jbc.M605708200
77. Hoffman MP, Engbring JA, Nielsen PK, Vargas J, Steinberg Z, Karmand AJ, et al. Cell type-specific differences in glycosaminoglycans modulate the biological activity of a heparin-binding peptide (RKRLQVQLSIRT) from the G domain of the laminin alpha1 chain. J Biol Chem 2001; 276: 22077-85; PMID:11304538; http://dx.doi.org/10.1074/jbc.M100774200
78. Engbring JA, Hoffman MP, Karmand AJ, Kleinman HK. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan. Cancer Res 2002; 62:3549-54; PMID:12068003
79. Bass MD, Morgan MR, Humphries MJ. Syndecans shed their reputation as inert molecules. Sci Signal 2009; 2:pe18; PMID:19336838; http://dx.doi.org/10. 1126/scisignal.264pe18
80. Lopes CC, Toma L, Pinhal MA, Porcionatto MA, Sogayar MC, Dietrich CP, et al. EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase. Biochimie 2006; 88:1493-504; PMID:16793191; http://dx.doi.org/10. 1016/j.biochi.2006.04.009
81. Tkachenko E, Rhodes JM, Simons M. Syndecans: new kids on the signaling block. Circ Res 2005; 96:488-500; PMID:15774861; http://dx.doi.org/10.1161/01. RES.0000159708.71142.c8
82. Alexopoulou AN, Multhaupt HA, Couchman JR. Syndecans in wound healing, inflammation and vascular biology. Int J Biochem Cell Biol 2007; 39: 505-28; PMID:17097330; http://dx.doi.org/10.1016/j.biocel.2006.10.014
83. Morgan MR, Humphries MJ, Bass MD. Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 2007; 8:957-69; PMID: 17971838; http://dx.doi.org/10.1038/nrm2289
84. Gama-de-Souza LN, Cyreno-Oliveira E, Freitas VM, Melo ES, Vilas-Boas VF, Moriscot AS, et al. Adhesion and protease activity in cell lines from human salivary gland tumors are regulated by the laminin-derived peptide AG73, syndecan-1 and beta1 integrin. Matrix Biol 2008; 27:402-19; PMID:18378436; http://dx.doi.org/10.1016/j.matbio.2008.02.007
85. Paulsson M, Deutzmann R, Timpl R, Dalzoppo D, Odermatt E, Engel J. Evidence for coiled-coil α-helical regions in the long arm of laminin. EMBO J 1985; 4:309-16; PMID:3848400
86. Schéele S, Falk M, Franzén A, Ellin F, Ferletta M, Lonai P, et al. Laminin alpha1 globular domains 4-5 induce fetal development but are not vital for embryonic basement membrane assembly. Proc Natl Acad Sci U S A 2005; 102:1502-6; PMID:15668394; http://dx.doi.org/10.1073/pnas.0405095102
87. Iijima H, Negishi Y, Omata D, Nomizu M, Aramaki Y. Cancer cell specific gene delivery by laminin-derived peptide AG73-labeled liposomes. Bioorg Med Chem Lett 2010; 20:4712-4; PMID:20615691; http://dx.doi.org/10.1016/j.bmcl.2010.04. 034
88. Negishi Y, Omata D, Iijima H, Hamano N, Endo-Takahashi Y, Nomizu M, et al. Preparation and characterization of laminin-derived peptide AG73-coated liposomes as a selective gene delivery tool. Biol Pharm Bull 2010; 33:1766-9; PMID:20930391; http://dx.doi.org/10.1248/bpb.33.1766
89. Hozumi K, Otagiri D, Yamada Y, Sasaki A, Fujimori C, Wakai Y, et al. Cell surface receptor-specific scaffold requirements for adhesion to laminin-derived peptide-chitosan membranes. Biomaterials 2010; 31:3237-43; PMID:20122724; http://dx.doi.org/10.1016/j.biomaterials.2010.01.043
90. Mochizuki M, Kadoya Y, Wakabayashi Y, Kato K, Okazaki I, Yamada M, et al. Laminin-1 peptide-conjugated chitosan membranes as a novel approach for cell engineering. FASEB J 2003; 17:875-7; PMID: 12626440
91. Yamada Y, Hozumi K, Aso A, Hotta A, Toma K, Katagiri F, et al. Laminin active peptide/agarose matrices as multifunctional biomaterials for tissue engineering. Biomaterials 2012; 33:4118-25; PMID: 22410171; http://dx.doi.org/ 10.1016/j.biomaterials.2012.02.044
92. Yamada Y, Katagiri F, Hozumi K, Kikkawa Y, Nomizu M. Cell behavior on protein matrices containing laminin a1 peptide AG73. Biomaterials 2011; 32: 4327-35; PMID:21420730; http://dx.doi.org/10.1016/j.biomaterials.2011.02.052
93. Ponce ML, Nomizu M, Delgado MC, Kuratomi Y, Hoffman MP, Powell S, et al. Identification of endothelial cell binding sites on the laminin gamma 1 chain. Circ Res 1999; 84:688-94; PMID:10189356; http://dx.doi.org/10.1161/01.RES.84.6. 688
94. Nomizu M, Yokoyama F, Suzuki N, Okazaki I, Nishi N, Ponce ML, et al. Identification of homologous biologically active sites on the N-terminal domain of laminin alpha chains. Biochemistry 2001; 40:15310-7; PMID:11735413; http://dx.doi.org/10.1021/bi011552c
95. Ponce ML, Kleinman HK. Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains. Exp Cell Res 2003; 285:189-95; PMID:12706114; http://dx.doi.org/10.1016/S0014-4827(03)00056-9
96. Kuratomi Y, Nomizu M, Tanaka K, Ponce ML, Komiyama S, Kleinman HK, et al. Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells. Br J Cancer 2002; 86:1169-73; PMID:11953867; http://dx.doi.org/10.1038/sj.bjc.6600187
97. Lugassy C, Kleinman HK, Vernon SE, Welch DR, Barnhill RL. C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell-less chick chorioallantoic membrane assay. Br J Dermatol 2007; 157:780-2; PMID: 17711523; http://dx.doi.org/10.1111/j.1365-2133.2007.08120.x
98. Ponce ML, Nomizu M, Kleinman HK. An angiogenic laminin site and its antagonist bind through the alpha (v)beta3 and alpha5beta1 integrins. FASEB J 2001; 15: 1389-97; PMID:11387236; http://dx.doi.org/10.1096/fj.00-0736com
99. Nascimento CF, de Siqueira AS, Pinheiro JJ, Freitas VM, Jaeger RG. Laminin-111 derived peptides AG73 and C16 regulate invadopodia activity of a human adenoid cystic carcinoma cell line. Exp Cell Res 2011; 317:2562-72; PMID:21924264; http://dx.doi.org/10.1016/j.yexcr.2011.08.022
100. Ponce ML, Hibino S, Lebioda AM, Mochizuki M, Nomizu M, Kleinman HK. Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth. Cancer Res 2003; 63:5060-4; PMID:12941835
101. Hamano N, Negishi Y, Fujisawa A, Manandhar M, Sato H, Katagiri F, et al. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor. Int J Pharm 2012; 428:114-7; PMID: 22421321; http://dx.doi.org/10.1016/j.ijpharm.2012.02.006